Fundz

Villya reported raising $250,000 in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEDec 18, 2023$250K of $10M raised

Amount Raised

$250,000

$250,000 sold, per SEC Form D (first sale Dec 8, 2023)

Round Type

Venture

MelbourneHealthcare

Quick answer

VILLYA raised $250,000 in a funding round, dated December 8, 2023. VILLYA is based in Melbourne, Florida, United States.

How much did VILLYA raise?
VILLYA raised $250,000 in a funding round on December 8, 2023.
What does VILLYA do?
Villya pharmaceuticals is a ground breaking company that has developed a new drug to treat FGS or Female Genital Schistosomiasis.
Where is VILLYA based and how big is it?
VILLYA is based in Melbourne, Florida, United States.
Who are the decision-makers at VILLYA?
Fundz holds 1 contact at VILLYA. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as VILLYA that raised within 45 days of this round, from Fundz verified event records.

  • Athos Therapeutics, Inc. raised $20M on January 22, 2024.
  • Restor3D raised $21M on January 22, 2024.
  • ROM Technologies raised $200K (Seed) on January 19, 2024.
  • FluxWear raised $1M (Seed) on January 19, 2024.
  • Singletto raised $65K (Pre-Seed) on January 17, 2024.
  • Streamex Corp. raised $1.5M (Seed) on January 12, 2024.

Who to call at VILLYA, and when

A new round usually means VILLYA is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VILLYA raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VILLYA, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VILLYA. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VILLYA

Location

6300 N. WICKHAM ROAD

Melbourne, Florida, United States

About

Villya pharmaceuticals is a ground breaking company that has developed a new drug to treat FGS or Female Genital Schistosomiasis. Villya also has developed a new liquid form of Praziquantel (patent pending) an essential anti-parasitic drug to treat Schistosomiasis, tapes worms and liver flukes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VILLYA raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for VILLYA's next move

See what Strategic adds

VILLYA raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.